Your body uses the ALG12 gene to help add sugar chains to newly made proteins, a step that helps many proteins fold and work properly. If this gene does not work well, proteins may not function as they should, causing an inherited condition called ALG12-CDG. People with pathogenic variants in the ALG12 gene often have low muscle tone, developmental delay, feeding difficulties, and problems with growth, learning, or seizures. This gene plays an important role in early development, so signs usually begin in infancy.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some give the directions for producing proteins, the parts of cells that do the work. Others mainly control when certain processes happen, where they happen, and how active they are. As a group, genes influence how the body develops and functions, and they can also affect how you respond to food, stress, and medications. You can find a deeper overview of this topic in the LearnHub.
Overview
ALG12Gene function
What if the gene works
The ALG12 gene helps cells add part of a sugar chain to newly made proteins. This supports proper protein folding and transport, especially in the endoplasmic reticulum, a cell compartment that processes proteins.
Risk
What if the gene does not work
Pathogenic variants in the ALG12 gene can cause a congenital glycosylation condition with developmental delay, low muscle tone, feeding problems, and sometimes seizures. Milder and more severe variants can change when symptoms begin and how much support a person needs.
Treatment
What does that mean for your treatment
For pathogenic variants in the ALG12 gene, no gene-specific treatment or management approach is currently established. Care is based on the person’s symptoms, and the ALG12 gene is being studied within broader congenital disorders of glycosylation research rather than as a current drug target in routine care.
Conditions associated with ALG12
Gene function
What if the gene works
Inside the endoplasmic reticulum, the ALG12 gene helps cells build sugar tags that are attached to many proteins. These tags are part of a normal finishing process that helps proteins take shape and move through the cell. This work supports routine cell activity in many tissues.
Inside the endoplasmic reticulum, the ALG12 gene helps build the sugar chain used for N-linked glycosylation. Its protein adds a mannose sugar at a specific step so the tag can be completed in the right order.
Many newly made proteins need these sugar tags before they can fold into a stable shape. By supporting that tagging process, the ALG12 gene helps proteins mature more smoothly and move to the places where they are needed.
Sugar tags also act like handling labels for proteins as they travel through the cell. This support helps cells sort and process many proteins in a steady, organized way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or the way the body reacts to environmental influences. Many variants do not cause any noticeable effects and simply represent natural genetic variation. In some cases, though, a variant can more strongly affect how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ALG12 gene can change the shape, stability, or activity of the ALG12 protein, which may disrupt a key sugar-adding step used to finish many proteins. This helps explain how ALG12 gene variants affect protein glycosylation, meaning some proteins are built with incomplete sugar chains and may not fold or travel through the cell normally. Milder variants often leave some activity, while more severe variants can greatly reduce it and are often linked to earlier or broader symptoms.
How variants are linked to conditions
Pathogenic variants in the ALG12 gene cause ALG12-CDG, also called congenital disorder of glycosylation type Ig. People with this condition often have developmental delay, low muscle tone, growth problems, and differences in brain, immune, liver, or digestive function, although features vary. In information about ALG12 gene variants and congenital disorder of glycosylation, this is the main diagnosis linked to the gene. Genetic testing that finds two pathogenic variants in the ALG12 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common in the general population and are a normal feature of human biology. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when multiple genes and environmental factors also play a role. In other cases, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ALG12, risk is mainly affected by family history and whether both biological parents carry a harmful change in the ALG12 gene. When both parents are carriers, each pregnancy has a 25% chance of being affected. Having parents who are blood relatives can also raise the chance that both carry the same change.
Inheritance of ALG12 variants
ALG12 gene inheritance is autosomal recessive. This means a person usually inherits one altered copy of the ALG12 gene from each parent. Parents who each carry one variant are often unaffected themselves, and with each pregnancy they have a 25% chance of having a child with the condition, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant. Sons and daughters are affected at the same rate.
What does my ALG12 result mean for my family?
For families with an ALG12-related condition, it is usually inherited in a recessive pattern, so parents are often healthy carriers and brothers or sisters may also be affected or be carriers. Close relatives may also carry the same gene change, especially siblings. For many families, this means the result can be relevant when thinking about other children or future pregnancies.
Genetic information
Genetic testing
How you find out about variants
ALG12 genetic testing usually uses a blood or saliva sample. A lab reads the ALG12 gene, often as part of a multigene panel or exome sequencing, to look for variants that may help explain symptoms or confirm carrier status in a family.
When should I consider getting a genetic test?
Genetic testing for the ALG12 gene may be considered if a child has signs of this rare inherited condition, such as developmental delay, low muscle tone, feeding problems, seizures, or unexplained liver or bleeding issues. It can also help when a close family member has a known ALG12 variant.
A genetic result is only one part of your health story
Genetic findings can be informative, but what they show depends on the condition and on the specific type of variant. Many other factors also shape how the body works over time, including age, environment, lifestyle, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, do less for another, or cause more side effects in someone else. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way medications work. It studies patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how the body handles a drug or how strongly that drug works. This information can help support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the ALG12 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so general health concerns or questions about treatment and side effects are best discussed with your doctor.